So when LABS CEO stated they have over 20 'strong' clinicaltrials, many in late stage then you have to ask yourself where are they all being conducted? We already know the "who"...with their 'large traditional global phamaceutical partner' and NOT by coincidence, Pfizer hooked up with USC way back in 2013 for new 'innovative' solutions including cancer. That 2013 hook up between Pfizer and USC...where the LABS Libby study is being conducted, the timing of 2013 hooks up to having over 20 strong clincial trials, many in LATE STAGE.....ie PHASE 3.